Sensus Healthcare, Inc. has installed the first SRT-100?? System in Ireland at Dublin's Beacon Hospital. The system will provide a highly efficacious and non-invasive solution to treat the growing numbers of non-melanoma skin cancer patients in Ireland, which is estimated by the Irish Cancer Society to number 12,000 annually and growing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +10.91% | +10.59% | +59.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.32% | 55.58M | |
-15.28% | 19.22B | |
-44.98% | 2.63B | |
+17.00% | 1.86B | |
-0.51% | 1.66B | |
+25.65% | 1.23B | |
-13.90% | 1.05B | |
-21.76% | 894M | |
-3.53% | 740M | |
-20.73% | 687M |
- Stock Market
- Equities
- SRTS Stock
- News Sensus Healthcare, Inc.
- Sensus Healthcare Completes Installation of Its First Srt System in Ireland